CurrentRheuma
Get Weekly

Topic · page 10 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 361–400 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Arthritis Care Res (Hoboken)

    The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis

    Diagnostic or prognostic study

  2. Lupus

    rs6897932 (C>T) and rs987106 (A>T) variants in the IL7RA gene are correlated with the susceptibility and the clinical features of systemic lupus erythematosus

    Case-control study

  3. Lupus

    Sexual status of female systemic lupus erythematosus patients: A qualitative study

    Research article

  4. Lupus Sci Med

    Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes

    Cohort study

  5. Semin Arthritis Rheum

    Development of clinical manifestations in individuals positive for antiphospholipid antibodies according to the 2023 ACR/EULAR serological domains

    Cohort study

  6. Arthritis Rheumatol

    Nationwide Temporal Trends in Adverse Pregnancy Outcomes and Treatments in Systemic Lupus Erythematosus Pregnancy Over Two Decades in Sweden

    Cohort study

  7. Rheumatology (Oxford)

    CD72 downregulation on DN2 B cells is associated with disease activity and resistance to rituximab in systemic lupus erythematosus

    Mechanistic study

  8. Arthritis Rheumatol

    Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring

    Cross-sectional study

  9. Arthritis Rheumatol

    Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study

    Randomized controlled trial

  10. Rheumatology (Oxford)

    Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework

    Cohort study

  11. Arthritis Rheumatol

    Weighing Dose‐Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus

    Cohort study

  12. Rheumatology (Oxford)

    Objective and subjective sleep assessment in systemic lupus erythematosus and association with disease characteristics and quality of life

    Case-control study

  13. Lupus Sci Med

    Induction treatment of lupus nephritis: to pulse or not to pulse? Whether ’tis nobler to universally or selectively prescribe

    Research article

  14. Arthritis Rheumatol

    Molecular Stratification of Antiphospholipid Syndrome Through Integrative Analysis of the Whole‐Blood RNA Transcriptome

    Cross-sectional study

  15. Lupus

    Cytomegalovirus infection and its association with systemic lupus erythematosus: Systematic review and meta-analysis

    Meta-analysis

  16. Rheumatology (Oxford)

    Vascular events in autoantibody-defined clusters of SLE: a 12-year prospective cohort study

    Cohort study

  17. Lupus

    The impact of a peer-mentoring intervention on self-reported flare and disease activity among African American women with Systemic Lupus Erythematosus (SLE)

    Secondary analysis

  18. Lupus

    Phenotypic clustering of cardiovascular risk profiles in systemic lupus erythematosus

    Cohort study

  19. Arthritis Rheumatol

    Myeloid‐Derived Suppressor Cell–Derived Interferon‐β Promotes T Follicular Helper Cell Response and Exacerbates Lupus Development

    Mechanistic study

  20. Lupus

    Anxiety in childhood onset lupus: Longitudinal anxiety symptom screening

    Cohort study

  21. Arthritis Res Ther

    Real-world validation of the SLERPI diagnostic model with concordance and discordance analysis across established SLE classification criteria

    Diagnostic or prognostic study

  22. Lupus Sci Med

    Statin therapy in systemic lupus erythematosus: a meta-analysis of disease activity and inflammatory biomarkers

    Meta-analysis

  23. Lupus Sci Med

    Serum S100A8 as a potential biomarker for diagnosis of antiphospholipid syndrome and risk stratification among aPL carriers

    Diagnostic or prognostic study

  24. Lupus

    Impact of hydroxychloroquine on pregnancy outcomes in systemic lupus erythematosus: A 25 years retrospective cohort study from Asia

    Cohort study

  25. Rheumatology (Oxford)

    Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus

    Cohort study

  26. Rheumatology (Oxford)

    Does adding concomitant immunosuppressive therapy to belimumab provide additional benefits in SLE? Results from the BEL-Spain Registry

    Cohort study

  27. Rheumatology (Oxford)

    Foetal echocardiographic surveillance in anti-SSA/Ro-SSB/La-positive SLE pregnancies: risk stratification of congenital heart block

    Cohort study

  28. Lancet Rheumatol

    Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study

    Cohort study

  29. Ann Rheum Dis

    Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review

    Research article

  30. Arthritis Care Res (Hoboken)

    Development of the 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria, Phase III ‐C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions

    Diagnostic or prognostic study

  31. Rheumatology (Oxford)

    Pancarditis and fibrosis as hallmarks of lupus myocarditis: clinical features, imaging findings and outcomes

    Cohort study

  32. Scand J Rheumatol

    Multidimensional factors affecting mortality and causes of death in patients with systemic lupus erythematosus: a Finnish cohort study with more than 20 years of follow-up

    Cohort study

  33. JAMA Netw Open

    Cost-Effectiveness of Early vs Delayed Belimumab Treatment for Systemic Lupus Erythematosus

    Research article

  34. J Rheumatol

    Association of Daily Glucocorticoid Dose With Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Data From the Almenara Lupus Cohort

    Cohort study

  35. Lupus Sci Med

    Trajectories of long-term eGFR and proteinuria in lupus nephritis: a real-world biopsy-proven cohort study

    Cohort study

  36. Arthritis Rheumatol

    Prothrombotic Activation of Platelet Pannexin‐1 Channels in Antiphospholipid Syndrome

    Mechanistic study

  37. Rheumatology (Oxford)

    Validation of the revised definition of lupus low disease activity in patients with SLE

    Cohort study

  38. Lupus

    Ethnic differences in disease activity among patients with systemic lupus erythematosus in a universal public healthcare system

    Cross-sectional study

  39. Lupus Sci Med

    Alterations in the DTI-ALPS index and choroid plexus volume as brain–immune interfacing indicators in neuropsychiatric lupus erythematosus with inflammatory phenotype

    Cross-sectional study

  40. Arthritis Rheumatol

    Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?

    Meta-analysis

All 1,848 Briefs in ExploreShowing Briefs 361–400 of 1,848, newest first